Parecoxib sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H17N2O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EB87433V6F, chemically known as propanamide, n-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, sodium salt but more generally known as parecoxib sodium, which bears US NIH Compound Identifier 9576744. European Medicines Agency schedules Parecoxib sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12548MIG. Most nations, for tariff and trade purposes, schedule parecoxib sodium under HS 29350090 and SITC 51580. As of Q4 2014, PARECOXIB SODIUM remains US FDA's Preferred Term for this commodity. Parecoxib sodium bears US NLM identifiers UMLS ID C0915144 and NCI Concept Code C73831. SMILES: CCC(=O)[N-]S(=O)(=O)C1CCC(CC1)C2C(ONC2C3CCCCC3)C.[NA+].